- Home
- USBC vs AGL Comparison
USBC vs AGL Comparison
Compare USBC & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USBC
- AGL
- Stock Information
- Founded
- USBC N/A
- AGL 2016
- Country
- USBC
- AGL United States
- Employees
- USBC 6
- AGL N/A
- Industry
- USBC
- AGL Managed Health Care
- Sector
- USBC
- AGL Health Care
- Exchange
- USBC Nasdaq
- AGL Nasdaq
- Market Cap
- USBC 317.2M
- AGL 276.6M
- IPO Year
- USBC N/A
- AGL 2021
- Fundamental
- Price
- USBC $0.74
- AGL $0.58
- Analyst Decision
- USBC
- AGL Hold
- Analyst Count
- USBC 0
- AGL 17
- Target Price
- USBC N/A
- AGL $2.79
- AVG Volume (30 Days)
- USBC N/A
- AGL 10.6M
- Earning Date
- USBC N/A
- AGL 11-04-2025
- Dividend Yield
- USBC N/A
- AGL N/A
- EPS Growth
- USBC N/A
- AGL N/A
- EPS
- USBC N/A
- AGL N/A
- Revenue
- USBC N/A
- AGL $5,885,571,000.00
- Revenue This Year
- USBC N/A
- AGL N/A
- Revenue Next Year
- USBC N/A
- AGL $5.76
- P/E Ratio
- USBC N/A
- AGL N/A
- Revenue Growth
- USBC N/A
- AGL 5.21
- 52 Week Low
- USBC N/A
- AGL $0.56
- 52 Week High
- USBC N/A
- AGL $6.08
- Technical
- Relative Strength Index (RSI)
- USBC 39.29
- AGL 23.45
- Support Level
- USBC $0.78
- AGL $0.60
- Resistance Level
- USBC $0.87
- AGL $0.86
- Average True Range (ATR)
- USBC 0.08
- AGL 0.07
- MACD
- USBC -0.01
- AGL -0.01
- Stochastic Oscillator
- USBC 14.51
- AGL 3.88
About USBC USBC Inc.
USBC Inc is a non-invasive medical diagnostics. The group is focused on the development and commercialization of proprietary sensor technology utilizing radio and microwave dielectric spectroscopy. Its Sensor technology elicits a dielectric response that is different for every molecule. The group considers the business to currently have one operating segment: the development of its radio frequency spectroscopy technology, with a first focus on non-invasively ascertaining blood glucose levels.
About AGL agilon health inc.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.